First Heartland Consultants, Inc. Moderna, Inc. Transaction History

First Heartland Consultants, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $587,132 - $958,126	-2,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $386,771 - $844,431	1,743 Added 203.38%	2,600 $1 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $111,332 - $201,377	857 New	857 $201,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

Stay updated on First Heartland Consultants, Inc. with notifications on news.